Trials / Completed
CompletedNCT00435461
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,000 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone furoate and fexofenadine | Fluticasone furoate and fexofenadine |
Timeline
- Start date
- 2006-12-20
- Primary completion
- 2007-02-01
- Completion
- 2007-02-28
- First posted
- 2007-02-15
- Last updated
- 2018-03-07
- Results posted
- 2018-02-05
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00435461. Inclusion in this directory is not an endorsement.